PLoS ONE (Jan 2020)

Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline.

  • Samuel Asanad,
  • Michele Fantini,
  • William Sultan,
  • Marco Nassisi,
  • Christian M Felix,
  • Jessica Wu,
  • Rustum Karanjia,
  • Fred N Ross-Cisneros,
  • Abhay P Sagare,
  • Berislav V Zlokovic,
  • Helena C Chui,
  • Janice M Pogoda,
  • Xianghong Arakaki,
  • Alfred N Fonteh,
  • Alfredo A Sadun,
  • Michael G Harrington

DOI
https://doi.org/10.1371/journal.pone.0232785
Journal volume & issue
Vol. 15, no. 5
p. e0232785

Abstract

Read online

BackgroundAlzheimer's disease (AD) pathology precedes symptoms and its detection can identify at-risk individuals who may benefit from early treatment. Since the retinal nerve fiber layer (RNFL) is depleted in established AD, we tested whether its thickness can predict whether cognitively healthy (CH) individuals have a normal or pathological cerebrospinal fluid (CSF) Aß42 (A) and tau (T) ratio.MethodsAs part of an ongoing longitudinal study, we enrolled CH individuals, excluding those with cognitive impairment and significant ocular pathology. We classified the CH group into two sub-groups, normal (CH-NAT, n = 16) or pathological (CH-PAT, n = 27), using a logistic regression model from the CSF AT ratio that identified >85% of patients with a clinically probable AD diagnosis. Spectral-domain optical coherence tomography (OCT) was acquired for RNFL, ganglion cell-inner plexiform layer (GC-IPL), and macular thickness. Group differences were tested using mixed model repeated measures and a classification model derived using multiple logistic regression.ResultsMean age (± standard deviation) in the CH-PAT group (n = 27; 75.2 ± 8.4 years) was similar (p = 0.50) to the CH-NAT group (n = 16; 74.1 ± 7.9 years). Mean RNFL (standard error) was thinner in the CH-PAT group by 9.8 (2.7) μm; p ConclusionsOur retinal data predict which individuals have CSF biomarkers of AD pathology before cognitive deficits are detectable with 87% sensitivity. Such results from easy-to-acquire, objective and non-invasive measurements of the RNFL merit further study of OCT technology to monitor or screen for early AD pathology.